One poster found patients with uncontrolled asthma had improved outcomes after escalating to triple therapy, while the other found a substantial portion of patients adherent to a dual therapy reported ...

Two posters presented at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting evaluated real-world biologic utilization for patients with severe, uncontrolled asthma.

Among patients with asthma who received four doses of depemokimab over 2 years, the annualized exacerbation rate was low, ...

Out of more than 700 entries in an Illinois Asthma Calendar contest, Glenview Middle School students snapped up almost a third of the 24 winning slots. Seven Glenview fifth-graders were picked to have ...